Obstetrics & Gynecology Doctors in Springville, UT Accepting Medicare

2 Obstetrics & Gynecology doctors found. Showing 1 - 2

Dr. Steven Greg Nance, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 672 W 400 S Ste 100, Springville, UT 84663 Phone: 801-489-0111    Fax: 801-489-0537

Jeff David Nance, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 672 W 400 S, Suite 100, Springville, UT 84663 Phone: 801-360-6784    Fax: 801-489-0537

News Archive

A heart defibrillator at home does not guarantee survival from a heart attack

A new study has found that having a portable heart defibrillator does not raise the chances of survival in people who have heart attacks in their homes.

New drug treatment could reduce body weight in obese patients with rare genetic disorder

As part of a phase II study at Charité - Universitätsmedizin Berlin and the Berlin Institute of Health, two obese patients with a rare genetic disorder were given a drug treatment to stimulate the satiety center in the brain.

American Botanical Council honors excellence in herbal medicine

The 6th Annual American Botanical Council Celebration and Awards Ceremony took place last night, honoring individuals and companies who influence the present and future of the herbal medicine movement. The ABC event is part of the annual Natural Products Expo West trade show and Nutracon scientific conference, held in Anaheim, California.

With teamwork and partnerships, successes experienced in Millennium Villages can be extended globally

In this post in the Huffington Post's "Global Motherhood" blog, Jeffrey Sachs, director of the Earth Institute at Columbia University, Sonia Sachs, director of health at the Millennium Villages Project (MVP), and Prabhjot Singh, assistant professor of international and public affairs at the MVP, respond to a study on the MVP, published in the Lancet on Tuesday, writing, "These results ... reinforce the global effort to build effective, low-cost, community-led health care systems that can end millions of deaths of young children and pregnant women each year."

FDA gives Priority Review to Celgene's ABRAXANE sNDA for advanced pancreatic cancer

Celgene International Sàrl, a subsidiary of Celgene Corporation today announced that the U.S. Food and Drug Administration has assigned a Priority Review designation to the supplemental New Drug Application for the use of ABRAXANE (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in combination with gemcitabine for the first-line treatment of patients with advanced pancreatic cancer.

Read more Medical News

› Verified 5 days ago